Ecovyst Inc (ECVT)
🔔 Watch stock
Stock Watch
Stock Watch will tell you what changes at Ecovyst Inc.
Later $1 a month per stock — signing up is free, and you'll be the first to know when it launches.
Appears in These Scanners
This stock currently matches 5 of our scanner strategies — each hit links to the scanner.
Only genuine hits from verified scanners count; pure ranking metrics (P/E, P/S, and similar, which just sort the whole universe) don't count as a hit. View all scanners
Trading Day
Key levels of the most recently completed trading day — not a live quote.
52-Week Range
Current price 12.10 $ — 60% of the range above the low.
Lowest and highest closing price over the last 52 weeks. The marker shows where the current price sits within that range: close to the high speaks for strength, close to the low for weakness.
Basics
Performance
Technical Indicators
Calculated from the price history · as of 08/03/2026
Valuation
Profitability
Balance Sheet & Safety
Growth
Dividend
This stock currently pays no dividend.
Quality & Screener
AI Rating
Uses AIGeprüft am 10.07.2026 gegen den Geschäftsbericht (10-K) 2025 (eingereicht 27.02.2026) und die vier jüngsten Quartalsberichte (10-Q). Ecovyst erzielt keine KI-Umsätze — das Kerngeschäft ist Schwefelsäure-Recycling für Raffinerien. Der Geschäftsbericht enthält aber einen ausdrücklichen, über bloße Cybersecurity-Floskeln hinausgehenden Beleg für operativen KI-Einsatz: Das Unternehmen erklärt in den Risk Factors (Item 1A) des 10-K 2025, es habe begonnen, KI und andere neue Technologien in verschiedenen Bereichen seiner Abläufe einzusetzen (Forschung, Fertigung, Kommerzialisierung) und pruefe weitere Anwendungsfaelle. Damit ist ein operativer KI-Einsatz belegt, ohne dass KI eine eigene Umsatzquelle waere — nach dem Kriterienkatalog (Rang 3) lautet die Einstufung 'nutzt' (analog zur Argan/AGX-Einstufung). Das Endmarkt-Narrativ rund um Raffinerien/Alkylat hat keinen KI-Bezug und begruendet fuer sich kein 'verkauft'.
View the full file — quotes, sources, reviewed filings
„We have begun to deploy AI and other emerging technologies in various facets of our operations, and we continue to explore further use cases."
Wir haben begonnen, KI und andere neue Technologien in verschiedenen Bereichen unserer Abläufe einzusetzen, und wir prüfen weiterhin zusätzliche Anwendungsfälle.
„The rapid advancement of these technologies presents opportunities for us in research, manufacturing, commercialization, and other business endeavors, but also entails risks, including that AI-generated content, analyses, or recommendations we utilize could be deficient."
Der rasche Fortschritt dieser Technologien eröffnet uns Chancen in Forschung, Fertigung, Kommerzialisierung und anderen Geschäftsfeldern, birgt aber auch Risiken — etwa, dass von uns genutzte KI-generierte Inhalte, Analysen oder Empfehlungen mangelhaft sein könnten.
Filings Reviewed: 10-Q 2026-05-05 · 10-Q 2025-11-05 · 10-Q 2025-08-07 · 10-Q 2025-05-02 · 10-K 2026-02-27 · 10-K 2025-02-28
Rated on July 10, 2026 · How the Rating Is Built
What the Earnings Calls Reveal
Red flags promises repeatedly deferredBetween the closing quarter of 2023 and the opening quarter of 2026, Ecovyst reshaped itself from a dual business of sulfuric acid services and specialty catalysts into a pure sulfur specialist. Across the first two years of that stretch, several stated dates were pushed back: the 2024 full-year outlook, the leverage target and the start of recycling revenue. Management did, however, name and explain each of those shifts on the call itself; none was dropped quietly. Since the call for 2025-Q1 the picture is markedly cleaner, with quarterly targets met or beaten every time. The weak spots stem almost entirely from the catalyst business that has since been sold.
10 calls reviewed, 2023-Q4 through 2026-Q1 · As of August 3, 2026
2024 outlook cut in summer
On the call for 2023-Q4, management guided full-year 2024 adjusted EBITDA to 255 to 275 million dollars, plus free cash flow of 85 to 105 million. On the call for 2024-Q1 that range was explicitly reaffirmed without change. Just one quarter later, on the call for 2024-Q2, management cut it to 230 to 245 million, while the expected sales contribution of the catalyst joint venture was trimmed by 30 million. The range then held: it was reaffirmed on the call for 2024-Q3, and the call for 2024-Q4 reported an actual figure of 238 million, roughly ten percent below the midpoint of the original range but inside the revised one. So there was a single cut, not a series. Free cash flow, guided at the same time, came in above 85 million and thus inside the original range. The stated reason was the collapse in renewable diesel incentive credits from above 1.50 to below 0.50 dollars. An analyst objected on the same call that the credits had been falling for a while; management explained the lag by noting that it supplies technology licensors and that the effect only feeds through via deferred investment decisions and extended catalyst life.
Leverage ratio flat in 2024
On the call for 2023-Q4 the CFO announced that 2024 would bring nearly half a turn of deleveraging, moving substantially toward the stated target of below 2.5. That statement carried two caveats spelled out in the same sentence: the expected cash generation, and the assumption that no cash would be used for other capital allocation priorities. In fact net leverage stood at 3.0 at the end of 2023, rose to 3.3 per the call for 2024-Q2, and was back at 3.0 at the end of 2024. Net debt itself did fall: per the calls, cash rose from 88 to 146 million dollars with a single unchanged debt tranche. Only the ratio stayed put, because earnings dropped from 260 to 238 million. On the call for 2024-Q3 an analyst asked directly whether the target would be met by the end of 2025; the answer fell back on the generic rule of thumb of half a turn per year, with no commitment. On the call for 2025-Q1 the target was openly and explicitly deferred in favor of share buybacks, and the call for 2025-Q2 showed the figure rising to 3.5, which the same call attributed to the Waggaman acquisition and the buybacks; excluding both it would have been 3.2. The company only moved below the target through the sale of the catalyst business, reaching 1.2 per the call for 2025-Q4.
Market forecast doubled between calls
One figure used to justify the outlook was swapped between two adjacent calls without any explanation. On the call for 2023-Q4 management said North American capacity for renewable diesel and sustainable aviation fuel would grow by about 33 percent in 2024 and European capacity by 43 percent. Just two months later, on the call for 2024-Q1, the same year was described as over 70 percent in North America and 26 percent in Europe, with no comment, even though both sets of numbers served as evidence for the demand outlook. To be fair, these are third-party market projections rather than company targets, and the revision ran in both directions. The Euro 7 emissions standard, by contrast, does not qualify as a contradiction: the call for 2023-Q4 said it had been due for heavy-duty vehicles in 2027 and was delayed by two years, while the call for 2024-Q2 said it had been due in 2025 and was delayed for heavy-duty vehicles by four years. Both statements land on the same year, 2029, and the four-year deferral was then repeated unchanged on the calls for 2024-Q3 and 2024-Q4.
Recycling sales pushed twice and never delivered
On the call for 2023-Q4 management pointed to commercial sales of plastics recycling catalysts in early 2025. On the call for 2024-Q2 this became a ramp across 2025 and 2026, and on the call for 2024-Q4 a start between late 2025 and early 2026. On the call for 2025-Q2 the language was still about customers testing pilot samples. No commercial revenue was reported on any call up to the sale of the segment, and the business passed to the buyer with that sale. The promised recovery in sulfuric acid for nylon precursors, also flagged on the call for 2023-Q4, is a different case: what was promised there was never a boom, only a gain over a weak prior year, and per the calls management reported exactly that gain for both 2024 and 2025, albeit from a low level. For 2026 the call for 2025-Q4 expects a broadly flat level.
Expansion project went to the buyer
From 2023-Q4 through 2024-Q4 the 50 percent expansion of catalyst production in Kansas City was the central growth argument, explicitly described as backed by firm customer commitments and aimed at a ramp in 2026 and 2027, with capital spending raised accordingly. The later sale was not, however, a pivot without warning: the strategic review of the entire segment was announced in December 2024 and repeated on the calls for 2024-Q4, 2025-Q1 and 2025-Q2, each time with the explicit note that a full spectrum of options was on the table. What did slip was the timing: the review was to be completed by mid 2025, and as late as the call for 2025-Q2 in August management said it remained on that timeline. The outcome only came on the call for 2025-Q3 in November: sale of the entire segment for 556 million dollars, moving the expansion project and the customer commitments to the buyer. For balance, the other side belongs here too: since the call for 2025-Q1 every quarterly target has been met or beaten, the sale closed earlier than planned per the call for 2025-Q4, and most recently the call for 2026-Q1 showed adjusted EBITDA of 40 million dollars above the company's own range.
Management promises
-
2023-Q4 broken
Adjusted EBITDA for 2024 of 255 to 275 million dollars.
Cut once to 230 to 245 million on the call for 2024-Q2; the call for 2024-Q4 reported 238 million. The free cash flow guided at the same time, 85 to 105 million, was met at above 85 million.
-
2023-Q4 broken
Deleveraging by nearly half a turn during 2024 and substantial progress toward the below 2.5 target.
The pledge came with the explicit caveat that no cash would be used for other priorities. Net leverage stood at 3.0 at both the end of 2023 and the end of 2024, and at 3.3 in between per the call for 2024-Q2. Net debt did fall (cash from 88 to 146 million with an unchanged debt tranche), but the ratio held because earnings dropped. The target was openly deferred on the call for 2025-Q1.
-
2023-Q4 broken
Commercial sales of plastics recycling catalysts starting in early 2025.
Date pushed twice, on the calls for 2024-Q2 and 2024-Q4; the call for 2025-Q2 still referred to pilot samples. No commercial revenue reported up to the segment sale.
-
2024-Q2 broken
The weakness in renewable diesel will last 12 to 18 months, followed by recovery.
The identical 12 to 18 month window was repeated unchanged on the calls for 2024-Q3 and 2024-Q4, effectively resetting the clock twice. For 2025 only flat to slightly up was expected on the calls for 2025-Q1 and 2025-Q2.
-
2024-Q4 broken
Completion of the strategic review of the catalyst segment by mid 2025.
The call for 2025-Q2 in August 2025 still claimed the timeline held; the outcome was only announced on the call for 2025-Q3 in November.
-
2025-Q3 kept
Use of 450 to 500 million dollars of sale proceeds to repay the term loan, bringing net leverage below 1.5.
Confirmed on the call for 2025-Q4: 465 million repaid, net leverage of 1.2 at year end.
-
2025-Q4 open
Share repurchases of 25 to 40 million dollars during 2026.
The call for 2026-Q1 already reported 36 million repurchased, nearly exhausting the range in the first quarter. Final outcome still pending.
Based on public earnings call transcripts. Reviewed: 10 transcripts 2023-Q4 through 2026-Q1.
Growth Score
5 of 10 Solid growthTen checks against the annual reports — each one passed counts a point.
- Revenue grows by more than 15% a year over three years -4.1% failed
- More than 10% revenue growth is expected for the coming year 3.5% failed
- Share count grows by less than 3% a year -5.0% passed
- Revenue growth plus cash-flow margin add up to at least 40 ("Rule of 40") 12.4% failed
- Gross margin at 40% or higher and without meaningful erosion 21.9% failed
- Goodwill from acquisitions does not grow faster than revenue 25.9% passed
- Net debt below twice EBITDA 1.7 x EBITDA passed
- Operating cash flow covers the profits of the last three years 434 m passed
- Return on capital at 15% or higher, or up versus two years ago 6.9% passed
- Insiders hold at least 10% or are net buyers 1.9% failed
A criterion without figures counts neither as passed nor as failed; a score is only produced from 7 judgeable criteria upwards. Source: fundamental data. All ten criteria in detail
Highlighted are things our editorial team noticed: green = stands out as strong, red = deserves a closer look. No single metric is a verdict on its own — always read it in context.
Analysts & Price Target
The price target sits 30.2% above the current price.
- Consensus
- Strong Buy
Combined picture of the price targets and recommendations of every analyst covering the stock. Price targets are expectations for the next 12 months, not promises — and they often follow the price rather than predict it.
Next Reporting Date
- Expected Earnings per Share
- 0.17 $
Expected date of the next quarterly or annual figures. Dates do shift occasionally — only the invitation issued by the company is binding.
Revenue & Profit
Cash Flow
Balance Sheet
Margins
Per Share
Click the chart or tab into it, then use ← and → to step through the periods.
None of the selected stocks reports this metric. Pick another metric or switch between annual and quarterly.
· Total · per year
These companies report in different currencies — switch on “Indexed” or pick a margin for a fair comparison.
The figures could not be loaded right now.
Source: fundamental data
Quarterly Figures
| Quarter | EPS (Earnings Per Share) | EPS YoY (%) | Sales ($M) | Sales YoY (%) | Net Margin (%) | OCF ($M) | FCF ($M) |
|---|---|---|---|---|---|---|---|
| 2024: Q4 | -0.26 | -202.20 | 182 | 5.30 | -16.70 | 44 | 26 |
| 2025: Q1 | -0.03 | -395.10 | 143 | -10.90 | -2.50 | 10 | -14 |
| 2025: Q2 | 0.05 | -27.20 | 200 | 9.50 | 3.00 | 33 | 8 |
| 2025: Q3 | -0.70 | -672.20 | 205 | 14.40 | -38.70 | 55 | 53 |
| 2025: Q4 | 0.05 | – | 199 | 9.60 | 2.90 | 42 | 23 |
| 2026: Q1 | 0.04 | – | 215 | 50.20 | 2.00 | 17 | 3 |
- EPS (Earnings Per Share):
- Quarterly profit divided by the total share count — how much of the profit works out to a single share.
- YoY (Year over Year):
- Change versus the same quarter a year ago — this is how you compare without seasonal distortion (e.g. the holiday shopping season).
- Sales:
- All revenue for the quarter, before any costs are deducted — the top line of the income statement.
- Net Margin:
- What percentage of sales is left over as profit in the end. Negative means the company is posting a loss.
- OCF (Operating Cash Flow):
- The cash that actually flows into the till from the core business during the quarter — harder to dress up than book profit.
- FCF (Free Cash Flow):
- Operating cash flow minus capital expenditures — the money that's genuinely free to use, say for paying down debt, buybacks, or dividends.
About the Company
Ecovyst Inc. bietet frische und regenerierte Schwefelsäureprodukte und -dienstleistungen in den USA und international an.
| Employees | 617 |
|---|---|
| Headquarters | Wayne, PA |
| Website | ecovyst.com |
| IPO Date | 3. Aug 2021 |
Management
| Name | Title | Birth Year |
|---|---|---|
| Kurt J. Bitting | CEO & Director | 1976 |
| Michael P. Feehan | VP & CFO | 1976 |
| Joseph S. Koscinski | Chief Administrative Officer, VP, Secretary & General Counsel | 1966 |
| Paul B. Hoelzer | Vice President of Operations | 1964 |
| H. Gene Shiels | Director of Investor Relations | – |
| Wendy Graham | Vice President of Marketing & Commercial Strategy | – |
| Kara L. Thornton | VP & Chief Human Resources Officer | 1976 |
| Colleen Grace Donofrio | Vice President of Environment & Sustainability | 1959 |
| Mark S. Baunchalk | Senior Vice President of Business Development & Strategy | 1958 |
Executives per the latest required filings; titles kept in their original language. Source: fundamental data.
Chart
Interactive price chart (TradingView).
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.